Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0111
-0.0001 (-0.90%)
Oct 8, 2025, 3:41 PM EDT
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $53.89 thousand as of October 8, 2025. Its market cap has decreased by -97.53% in one year.
Market Cap
53.89K
Enterprise Value
1.72M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 53.89K, a decrease of -99.94%. That is a compound annual growth rate of -52.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 53.89K | -97.08% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | 34.35M | 23.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2015 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |